1. Home
  2. ATRA vs MLEC Comparison

ATRA vs MLEC Comparison

Compare ATRA & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$17.92

Market Cap

99.1M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

N/A

Current Price

$0.42

Market Cap

4.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ATRA
MLEC
Founded
2012
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
99.1M
4.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ATRA
MLEC
Price
$17.92
$0.42
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
71.6K
131.3K
Earning Date
11-12-2025
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.97
N/A
Revenue
$151,930,000.00
N/A
Revenue This Year
N/A
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
$9.15
N/A
Revenue Growth
51.27
170.36
52 Week Low
$5.01
$0.39
52 Week High
$18.71
$8.00

Technical Indicators

Market Signals
Indicator
ATRA
MLEC
Relative Strength Index (RSI) 69.17 36.36
Support Level $14.37 $0.41
Resistance Level $18.37 $0.48
Average True Range (ATR) 1.19 0.05
MACD 0.49 0.01
Stochastic Oscillator 94.07 24.66

Price Performance

Historical Comparison
ATRA
MLEC

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: